COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 58: Articles 571-580  | Next

Agreement between self-reported COVID-19 and dried blood spot serology
Sheppard, N., Carroll, M. T. C., Borg, B. M., Toh, Z. Q., Licciardi, P., Smith, C. L., Ikin, J. F., Abramson, M. J., Walker-Bone, K., Lane, T. J.
10.1101/2025.04.08.25325501 — Posted: 2025-04-10
Implementation of oral health evidence-based practices in early care education settings across the U.S. during different COVID-19 periods
Tchoua, P., Patel, S., Starr, A. S., Rairigh, R., Smith, F., Willis, E. A.
10.1101/2025.04.09.25325529 — Posted: 2025-04-10
The Impacts of COVID-19 on routine immunization for children in Rwanda.
Mbonigaba, E., Yu, F., Renosa, M. D. C., Cho, F. N., Chen, Q., Chen, W., Denkinger, C. M., McMahon, S. A., Chen, S.
10.1101/2025.04.09.25325536 — Posted: 2025-04-10
Impact of Covid-19 Control Strategies on Health and GDP Growth Outcomes in 193 Sovereign Jurisdictions
Boyd, M., Baker, M. G., Kvalsvig, A., Wilson, N.
10.1101/2025.04.08.25325452 — Posted: 2025-04-10
Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up
Alves, K., Kotloff, K. L., McClelland, R. S., Hammershaimb, E. A., Kouassi, A., Plested, J. S., Kalkeri, R., Zhu, M., Cloney-Clark, S., Cai, Z., Smith, K., Kaba, M., Nelson, J., Mallory, R. M., Noriega, F.
10.1101/2025.04.09.25325550 — Posted: 2025-04-10
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection
Nooruzzaman, M., Butt, S. L., Rani, R., Ye, C., Martinez-Sobrido, L., Fang, Y., Diel, D. G.
10.1101/2025.04.09.647941 — Posted: 2025-04-10
Reconstructing the force of infection and immune fraction of the population via a single snapshot survey: a case study of COVID-19 in Japan
Okada, Y., Nishiura, H.
10.1101/2025.04.08.25325449 — Posted: 2025-04-09
Bayesian automatic screening of pneumoniaand lung lesions localization from CT scans. Acombined method toward a more user-centredand explainable approach
Moure Prado, A., Guerrero-Lopez, A., Arias-Londono, J. D., Godino-Llorente, J. I.
10.1101/2025.04.08.647710 — Posted: 2025-04-09
Mutations differentially affecting the coronavirus Mac1 ADP-ribose binding and hydrolysis activities indicate that it promotes multiple stages of the viral replication cycle
O Connor, J., Roy, A., Khattabi, R., Kerr, C. M., Schwarting, N., Alhammad, Y. M., Gao, P., Zhang, X., Deng, X., Fehr, A. R.
10.1101/2025.04.08.647734 — Posted: 2025-04-09
Transient, early, female-specific increase in cortical glial fibrillary acidic protein distribution in the Syrian hamster model of mild peripheral COVID-19
Rahmani Manesh, M., Wicki-Stordeur, L. E., York, N. S., Vendramelli, R., Warner, B., Vecchiarelli, H. A., Ranier-Pope, L., Khakpour, M., Bennouna, L. R., Tremblay, M.-E., Kobasa, D., Swayne, L. A.
10.1101/2025.04.08.647811 — Posted: 2025-04-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).